[{"address1": "201 Haskins Way", "address2": "Suite 230", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "(650) 407-2376", "website": "https://www.cero.bio", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "CERo Therapeutics Holdings, Inc., an immunotherapy company, focuses on advancing the development of engineered T cell therapeutics for the treatment of cancer. Its lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.", "fullTimeEmployees": 8, "companyOfficers": [{"maxAge": 1, "name": "Mr. Christopher B. Ehrlich M.B.A.", "age": 54, "title": "CEO & Chair", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 1080000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Andrew Albert Kucharchuk M.B.A.", "age": 43, "title": "Chief Financial Officer", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 252000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Kristen  Pierce Ph.D.", "age": 53, "title": "Chief Development Officer", "yearBorn": 1971, "fiscalYear": 2024, "totalPay": 360000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Lawrence  Corey M.D.", "age": 77, "title": "Co-founder & Head of Scientific Advisory Board", "yearBorn": 1947, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 7.66, "open": 7.85, "dayLow": 7.52, "dayHigh": 7.85, "regularMarketPreviousClose": 7.66, "regularMarketOpen": 7.85, "regularMarketDayLow": 7.52, "regularMarketDayHigh": 7.85, "payoutRatio": 0.0, "beta": 0.49, "volume": 19721, "regularMarketVolume": 19721, "averageVolume": 1103699, "averageVolume10days": 27780, "averageDailyVolume10Day": 27780, "bid": 5.53, "ask": 9.79, "bidSize": 2, "askSize": 2, "marketCap": 9064608, "fiftyTwoWeekLow": 6.71, "fiftyTwoWeekHigh": 896.0, "fiftyDayAverage": 8.4471, "twoHundredDayAverage": 66.96871, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 15488997, "forwardPE": -2.0324323, "profitMargins": 0.0, "floatShares": 1102750, "sharesOutstanding": 1205400, "sharesShort": 35067, "sharesShortPriorMonth": 16267, "sharesShortPreviousMonthDate": 1752537600, "dateShortInterest": 1755216000, "sharesPercentSharesOut": 0.0291, "heldPercentInsiders": 0.03546, "heldPercentInstitutions": 0.25767002, "shortRatio": 0.61, "shortPercentOfFloat": 0.0298, "impliedSharesOutstanding": 1205400, "bookValue": -8.544, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1751241600, "netIncomeToCommon": -41912760, "trailingEps": -502.73, "lastSplitFactor": "1:20", "lastSplitDate": 1749772800, "enterpriseToEbitda": -0.929, "52WeekChange": -0.96730435, "SandP52WeekChange": 0.16844666, "quoteType": "EQUITY", "currentPrice": 7.52, "targetHighPrice": 60.0, "targetLowPrice": 30.0, "targetMeanPrice": 45.0, "targetMedianPrice": 45.0, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 3302674, "totalCashPerShare": 2.74, "ebitda": -16679652, "totalDebt": 1152618, "quickRatio": 0.434, "currentRatio": 0.557, "returnOnAssets": -1.56888, "freeCashflow": -8613463, "operatingCashflow": -13367386, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CERO", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "shortName": "CERo Therapeutics Holdings, Inc", "longName": "CERo Therapeutics Holdings, Inc.", "epsTrailingTwelveMonths": -502.73, "epsCurrentYear": -15.39, "priceEpsCurrentYear": -0.48862895, "fiftyDayAverageChange": -0.9270997, "fiftyDayAverageChangePercent": -0.10975361, "twoHundredDayAverageChange": -59.44871, "twoHundredDayAverageChangePercent": -0.8877087, "priceToBook": -0.88014984, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "prevName": "Phoenix Biotech Acquisition Corp.", "nameChangeDate": "2025-08-29", "cryptoTradeable": false, "postMarketChangePercent": -0.265957, "postMarketPrice": 7.5, "postMarketChange": -0.02, "regularMarketChange": -0.14, "regularMarketDayRange": "7.52 - 7.85", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 1103699, "fiftyTwoWeekLowChange": 0.80999994, "fiftyTwoWeekLowChangePercent": 0.12071534, "fiftyTwoWeekRange": "6.71 - 896.0", "fiftyTwoWeekHighChange": -888.48, "fiftyTwoWeekHighChangePercent": -0.9916071, "fiftyTwoWeekChangePercent": -96.73044, "regularMarketChangePercent": -1.82767, "regularMarketPrice": 7.52, "corporateActions": [], "postMarketTime": 1756511302, "regularMarketTime": 1756497602, "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1638282600000, "exchange": "NCM", "messageBoardId": "finmb_1673740339", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "displayName": "CERo Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-08-30"}]